鼎康生物与魔境生物达成战略合作，共同推进AI赋能生物药全生命周期智能制造

关于 chi9iua

This author has not written his bio yet.
But we are proud to say that chi9iua contributed 85 entries already.

日志 chi9iua

鼎康生物与魔境生物达成战略合作，共同推进AI赋能生物药全生命周期智能制造

September 23, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

Chime Biologics Live Fireside Chat

September 17, 2026/在： Event, NewsRoom, Uncategorized/通过： chi9iua

从生物工艺到数字时代：鼎康生物亮相 Bioprocessing Summit 2026

August 14, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

[/av_two_third]

百亿美元交易的背后：商业化生产权益正在成为中国生物药对外授权交易的新价值密码

August 7, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

(English) Can New Entrants Win the Biosimilar Race? What Europe's Biosimilar Market Reveals About the Next Competitive Frontier

June 23, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

鼎康生物在全球生物药制造创新峰会上发布下一代全球生物药制造愿景

June 10, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

[/av_two_third]

鼎康生物与大熊制药达成战略合作，共同推进度普利尤单抗生物类似药全球开发与商业化

June 1, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

(English) From AI Vision to AI Execution

May 15, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

鼎康生物亮相BIO Equity Europe 2026——推动AI生物制药从概念走向现实

May 14, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

(English) Chime Biologics at BIO Equity Europe 2026 ---Turning AI into Biologics Reality Amid the New Global Biopharma Landscape

May 12, 2026/在： Uncategorized/通过： chi9iua

对不起，此内容只适用于English。 For the sake of viewer convenience, […]